Je was op zoek naar: response evaluable (Engels - Maltees)

response evaluable population
popolazzjoni ta’ rispons li seta’ jiġi evalwat

response not evaluable (ne)
rispons ma setax jiġi evalwat (ne)

n: response-evaluable patients
n: pazjenti b’rispons li seta’ jiġi

virologic response in evaluable subjectsa
rispons viroloġiku f’individwu li setgħu jiġu evalwatia

not evaluable
trattament ma jistax jiġi evalwat

clinically evaluable
klinikament evalwabbli

microbiologically evaluable (me)
mikrobijoloġikament evalwabbli (me)

not evaluable / not known
mhux evalwabbli/mhux magħruf

absent present not evaluable
preżenti

all evaluable patients engrafted.
il-pazjenti kollha li setgħu jiġu evalwati ġew imlaqqma.

a number of patients evaluable.
a numru ta’ pazjenti li jistgħu jiġu evalwati.

abbreviations: mcyr = major cytogenetic response, resp = responders, eval = evaluable.
abbrevjazzjonijiet: mcyr = rispons ċitoġenetiku maġġuri, resp=rispondenti, eval = evalwati.

36 patients were evaluable for efficacy.
36 pazjent ġew evalwati għall-effikaċja.

the complete molecular response rate was 48% (49 out of 102 evaluable patients).
ir-rata ta’ rispons molekulari komplet kienet 48% (49 minn 102 pazjenti li setgħu jkunu evalwati).

an objective response was observed for four of six evaluable adolescent in an interim analysis of study 5.
kien osservat rispons oġġettiv għal erbgħa minn sitt adolexxenti li setgħu jiġu evalwati f’analiżi interim ta’ studju 5.

c includes patients who were evaluable for response
c jinkludi pazjenti li jistgħu jiġu valutati għal rispons

forty patients were fully evaluable for response.
erbgħin pazjent kienu evalwabbli għal kollox għal rispons.

a total of 218 patients were evaluable for response.
total ta’ 218-il pazjent setgħu jiġu evlawati għal rispons.

three patients were not evaluable for response in study 1001, and 42 patients were not evaluable for response in study 1005.
tliet pazjenti ma setgħux jiġu evalwati għal rispons fi studju 1001, u 42 pazjenti ma setgħux jiġu evalwati għal rispons fi studju 1005

the overall response rate was 6.8% in the evaluable patients, and the median duration of response was weeks.
ir-rata totali tar-rispons kienet ta’ 6.8% fil-pazjenti evalwati, u ż-żmien medjan tar- rispons kien ta’ ġimgħat.